Key result
Streptozotocin-induced hyperglycemia increased aortic sinus atherosclerotic plaque area by approximately 50% and significantly reduced survival in high fat/high cholesterol diet-fed SR-B1-KO/hypoE mice.
Why the study?
Does streptozotocin-induced hyperglycemia aggravate diet-induced coronary artery disease and myocardial infarction in SR-B1-knockout/apoE-hypomorphic mice?
Does streptozotocin-induced hyperglycemia aggravate diet-induced coronary artery disease and myocardial infarction in SR-B1-knockout/apoE-hypomorphic mice?
Absolute Event Rate: 145000% vs 97600%
p-value: p=0.02
Hyperglycemia exacerbates atherosclerosis, atherothrombosis, myocardial fibrosis, and mortality in a mouse model of diet-induced coronary artery disease.
Diabetes is a risk factor for development of atherosclerotic cardiovascular disease. Animal model studies in mice revealed that hyperglycemia increases development of atherosclerosis in the aorta as well as myocardial fibrosis in surgical models of coronary artery ligation, however the impact of hyperglycemia on coronary artery atherosclerosis and subsequent heart disease is less clear. To investigate the effect of hyperglycemia on atherosclerosis and coronary heart disease, we used a mouse model of diet-induced coronary artery atherosclerosis and myocardial infarction, the high fat/high cholesterol diet-fed SR-B1 knockout/apoE-hypomorphic mouse. Hyperglycemia was induced in these mice by streptozotocin treatment. This increased high fat/high cholesterol diet-dependent atherosclerosis development (p=0.02) and necrotic core formation (p=0.0008) in atherosclerotic plaques in the aortic sinus but did not increase the extent of atherosclerosis in coronary arteries. However it did increase the extent of platelet accumulation in atherosclerotic coronary arteries (p=0.017). This was accompanied by increased myocardial fibrosis (p=0.005) and reduced survival (p=0.01) compared to control-treated, normoglycemic mice. These results demonstrate that streptozotocin-treatment exerted differential effects on the level of atherosclerosis in the aortic sinus and coronary arteries. These results also suggest that SR-B1-knockout/apoE-hypomorphic mice may be a useful non-surgical model of diabetic cardiomyopathy in the context of coronary artery atherothrombosis.
No takes yet. Share an insight, caveat, or question.
González et al. (2018) studied Diet-Induced Coronary Artery Disease and Myocardial Infarction (n=42). Streptozotocin (STZ) vs. Citrate buffer vehicle was evaluated on Aortic sinus atherosclerotic plaque cross-sectional area (µm2) in HFC diet fed mice (p=0.02). Streptozotocin-induced hyperglycemia increased aortic sinus atherosclerotic plaque area by approximately 50% and significantly reduced survival in high fat/high cholesterol diet-fed SR-B1-KO/hypoE mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: